Curis
CRIS
#11123
Rank
C$3.78 M
Marketcap
C$1.56
Share price
-0.88%
Change (1 day)
-33.21%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$33.22

According to Curis's latest financial reports the company's current EPS (TTM) is C-$33.15. In 2025 the company made an earnings per share (EPS) of C-$33.15 an increase over its 2024 EPS that were of C-$195.84.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$33.220.2%
2025C-$33.15-83.07%
2024C-$195.84-22.15%
2023C-$251.56-26.17%
2022C-$340.7022.3%
2021C-$278.58-25.37%
2020C-$373.29-30.93%
2019C-$540.44-2.02%
2018C-$551.58
2016C-$1,254-10%
2015C-$1,393138.1%
2014C-$585.0140%
2013C-$417.87-25%
2012C-$557.1666.67%
2011C-$334.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.82-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.96-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.36-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.93-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$7.02-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA